Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Shares Issued (2016 - 2025)

Moleculin Biotech's Shares Issued history spans 9 years, with the latest figure at $406000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $406000.0 for Q4 2025, up 40500.0% from a year ago — trailing twelve months through Dec 2025 was $19.3 million (up 9300.48% YoY), and the annual figure for FY2025 was $1.5 million, up 152600.0%.
  • Shares Issued for Q4 2025 was $406000.0 at Moleculin Biotech, down from $1.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $74.7 million in Q1 2021 to a low of -$74.6 million in Q3 2021.
  • The 4-year median for Shares Issued is $105500.0 (2023), against an average of $1.9 million.
  • The sharpest move saw Shares Issued tumbled 537.1% in 2021, then surged 40500.0% in 2025.
  • Year by year, Shares Issued stood at -$74.6 million in 2021, then skyrocketed by 99.72% to -$211000.0 in 2023, then surged by 100.47% to $1000.0 in 2024, then surged by 40500.0% to $406000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $406000.0, $1.1 million, and $17.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.